Ironwood Pharmaceuticals, Inc. - Class A Common Stock (IRWD)
4.2700
+0.9000 (26.71%)
NASDAQ · Last Trade: Jan 2nd, 6:28 PM EST
Detailed Quote
Previous Close
3.370
Open
4.595
Bid
4.290
Ask
4.300
Day's Range
4.200 - 5.780
52 Week Range
0.5271 - 4.775
Volume
84,898,578
Market Cap
683.32M
PE Ratio (TTM)
28.47
EPS (TTM)
0.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
2,254,688
Chart
About Ironwood Pharmaceuticals, Inc. - Class A Common Stock (IRWD)
Ironwood Pharmaceuticals is a biotechnology company focused on developing and commercializing innovative treatments for gastrointestinal diseases and disorders. The company primarily centers its research efforts on the discovery and development of medications that target specific pathways involved in gut health, thereby aiming to improve the quality of life for patients suffering from various gastrointestinal conditions. Ironwood engages in both in-house drug development and collaborations, working to bring new therapies to market that address unmet medical needs in the field of gastroenterology. Read More
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today announced financial guidance for full year 2026.
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its third quarter 2025 results and recent business performance.
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its second quarter 2025 results and recent business performance.
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
